x

Search for a diagnostic test

* (*) mandatory field

325 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CLCC Institut Bergonié
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CLCC Institut Paoli Calmettes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

PAYS DE LA LOIRE
NANTES

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, PALB2, RAD51C, RAD51D and TP53 genes)
CHU de Nantes - Institut de Biologie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Diagnosis of predisposition to breast and ovarian cancer, search of familial specific mutation and BRCA1/2 Ashkenazi Jewish founder mutations (Panel)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Search for somatic modifications in breast cancer (ERBB2 gene)
CLCC Institut Paoli Calmettes
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Bayern
MARTINSRIED/PLANEGG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes)
MVZ Martinsried GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
NEU-ULM

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
genetikum - Zweigniederlassung Neu-Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
UZ Leuven - Campus Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
BELGIUM

OOST-VLAANDEREN
GENT

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Centrum Medische Genetica Gent - Universitair Ziekenhuis Gent
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Cliniques Universitaires de Bruxelles - Hôpital Erasme
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Sachsen
DRESDEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 18 genes)
MVZ Mitteldeutscher Praxisverbund Humangenetik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
UNITED KINGDOM

South Glamorgan
CARDIFF

Accreditation Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes: Molecular diagnosis through sequencing and dosage analysis)
University Hospital of Wales
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, PALB2, RAD51C genes)
Medizinische Hochschule Hannover
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
MANNHEIM

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, PALB2, RAD51C, RAD51D, TP53 genes)
Zentrum für Humangenetik Mannheim
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

AUVERGNE-RHONE-ALPES
BRON

Accreditation Diagnosis of prediposition to hereditary breast and ovarian cancer (Panel)
CHU de Lyon HCL - GH Est
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, MRE11A, PALB2, RAD51C)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRCA3, BRIP1, CHEK2, NBN, RAD51D genes)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
BELGIUM

HAINAUT
GOSSELIES

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Institut de Pathologie et de Génétique
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, RAD51C genes)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
UNITED KINGDOM

Cambridgeshire
ST NEOTS

Accreditation Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
The Aplastic Anaemia Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Noord-Holland
AMSTERDAM

Accreditation Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (BRCA1 and BRCA2 gene)
Amsterdam UMC, locatie VUmc
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Universitair Ziekenhuis Brussel
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1, BRCA2 and CHEK2 gene)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Accreditation Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2 genes: Testing for known mutations in family members)
Newcastle upon Tyne Hospitals NHS Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
GÖTTINGEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 13 genes)
Institut für Humangenetik der Universität Göttingen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
MÜNSTER

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SWEDEN

Region Stockholm
SOLNA

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
Karolinska Universitetssjukhuset
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Sequence analysis: entire coding region, Detection of microdeletions/microduplications
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
NETHERLANDS

Zuid-Holland
ROTTERDAM

Accreditation Molecular diagnosis of Predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
Erasmus MC, Faculteitsgebouw
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Zuid-Holland
LEIDEN

Accreditation Diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1, BRCA2, CHEK2 and PALB2 gene)
LUMC - Leids Universitair Medisch Centrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Gelderland
NIJMEGEN

Accreditation Diagnosis of Breast and Ovarian Cancer (BARD1, BRCA1, BRCA2, CHEK2 and PALB2 gene)
Radboudumc - Radboud universitair medisch centrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
NETHERLANDS

Groningen
GRONINGEN

Accreditation Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
UMCG - Universitair Medisch Centrum Groningen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
BELGIUM

ANTWERPEN
ANTWERPEN-EDEGEM

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Centrum Medische Genetica - UZA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
IRELAND

County Dublin
DUBLIN

Accreditation Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
Children's Health Ireland @ Crumlin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pre-implantation diagnosis, Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C, RAD51D genes)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
FREIBURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, RAD51C genes)
SYNLAB MVZ Freiburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
LEIPZIG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHK2 genes)
MVZ Labor Dr. Reising-Ackermann und Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
CLCC Oscar Lambret
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Limburg
MAASTRICHT

Accreditation Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
Maastricht UMC+
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SWEDEN

Region Västra Götaland
GÖTEBORG

Accreditation Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Sahlgrenska Universitetssjuhuset
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (RAD51C gene: sequencing)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
HEIDELBERG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik am Universitätsklinikum Heidelberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Murcia
EL PALMAR

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Centro de Bioquímica y Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Rheinland-Pfalz
MAINZ

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universitätsmedizin Mainz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hessen
FRANKFURT AM MAIN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel, 10 genes)
Diagnosticum Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SWITZERLAND

Suisse Alémanique
AARAU

Accreditation Molecular diagnosis of RAD51C related diseases (RAD51C gene: sequencing and deletion analysis)
Kantonsspital Aarau
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis

More information
SWITZERLAND

Suisse Alémanique
AARAU

Accreditation Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 genes sequencing and deletion analysis)
Kantonsspital Aarau
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis

More information
AUSTRIA

STEIERMARK
GRAZ

Accreditation Diagnosis of hereditary breast and ovarian cancer (BRCA1, BRCA2, BARD1, BRIP1, CHEK2, MRE11, NBN, PALB2, PTEN, RAD50, RAD51C, RAD51D, and TP53 genes)
Medizinische Universität Graz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK1 genes)
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
MÜNSTER

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Labor Dr. Fenner & Kollegen MVZ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Schleswig-Holstein
KIEL

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, DH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Sachsen
LEIPZIG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
Institut für Humangenetik am Universitätsklinikum Leipzig
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
AUSTRIA

TIROL
INNSBRUCK

Accreditation Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Medizinische Universität Innsbruck
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
amedes genetics im MVZ wagnerstibbe
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
CANADA

Ontario
MISSISSAUGA

Accreditation Molecular Diagnosis of Familial Breast Cancer
Trillium Health Partners- Credit Valley Site
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2 genes)
laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CDH1, RAD51C, PPM1D, TP53 genes: sequencing, MLPA)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 18 genes)
UKE - Universitätsklinikum Hamburg-Eppendorf
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (RAD51D, PALB2, PTEN genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of hereditary breast and ovarian cancer (panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SWITZERLAND

Suisse Alémanique
SCHLIEREN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universität Zürich
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Mecklenburg-Vorpommern
GREIFSWALD

Accreditation Diagnosis of predisposition to breast and ovarian cancer (NGS panel: 13 genes)
Institut für Humangenetik der Universitätsmedizin Greifswald
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, RAD51C, RAD51D, TP53 genes)
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of sporadic breast carcinoma (AKT1, KRAS, PIK3CA, RAD54L, RB1CC1, SLC22A18)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
KARLSRUHE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
MVZ Labor PD Dr. Volkmann und Kollegen GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Thüringen
JENA

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Institut für Humangenetik am Universitätsklinikum Jena
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SWITZERLAND

Suisse Romande
LAUSANNE

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Synlab Lausanne
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, BRIP1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of susceptibility to tumors (melanoma, pancreas, kidney, breast-ovary, colon, skin cancer) (Panel)
CLCC Jean Perrin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
CLCC Institut Curie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
AACHEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universitätsklinikum Aachen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

NORMANDIE
CAEN

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
Centre François Baclesse
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
CANADA

Ontario
MISSISSAUGA

Accreditation Molecular Cytogenetic Solid Tumor Analysis (Paraffin Embedded Tissue ALK, MYC, ERBB2)
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of hereditary breast, colon and ovarian cancer syndromes (panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Sachsen
DRESDEN

Accreditation Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
TOULOUSE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
IUCT Oncopole - CLCC Institut Claudius Regaud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation Diagnosis of predisposition to breast, ovarian and colon cancer (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

AUVERGNE-RHONE-ALPES
GRENOBLE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CHU Grenoble Alpes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Molecular diagnosis of Familiar Breast and/or Ovarian Cancer (gene panel; ONC01v16.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Molecular diagnosis of Familiar Breast and/or Ovarian Cancer (gene panel incl CHEK2 gene; ONC02v16.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ESTONIA

Tartu
TARTU

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (panel)
Asper Biogene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Accreditation Diagnosis of inherited cancer predisposing syndrome (Panel)
CLCC Institut Gustave Roussy
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome
CLCC Jean Perrin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
SWITZERLAND

Suisse Romande
SION

Accreditation Diagnosis of hereditary cancer predisposition (panel)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Diagnosis of predipositon to tumor (melanoma, pancreas, kidney, breast-ovary, colon, skin cancer) (Panel)
CLCC Institut Paoli Calmettes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Gelderland
NIJMEGEN

Accreditation Molecular diagnosis of Hereditary Cancer (whole exome sequencing)
Radboudumc - Radboud universitair medisch centrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
GERMANY

Bayern
NEU-ULM

Accreditation Diagnosis of familial tumor syndromes (NGS screening panel: 40 genes)
genetikum - Zweigniederlassung Neu-Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
Laboratoire Alpigene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Accreditation Diagnosis of predisposition to ovarian cancer (Panel)
CLCC Institut Gustave Roussy
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Accreditation Diagnosis of predisposition to breast cancer (Panel : second intention)
CLCC Institut Gustave Roussy
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SWITZERLAND

Suisse Alémanique
ZÜRICH

Accreditation Diagnosis of hereditary tumor diseases (Panel - 43 genes)
Genetica AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of predisposition to breast, gastric and ovarian cancer (Panel)
CHU de Strasbourg - Hôpital de Hautepierre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Accreditation Diagnosis of predisposition to breast , ovarian and prostate cancer (Panel)
CLCC Georges François Leclerc
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Noord-Holland
AMSTERDAM

Accreditation Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (CHEK2 c.1100delC, BRCA1 and BRCA2 gene)
Amsterdam UMC, locatie AMC
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

NORMANDIE
ROUEN

Accreditation Diagnosis of rare genetic tumor (Phenotyping in oncogenetics) (Whole exome)
CHU de Rouen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
SWITZERLAND

Suisse Alémanique
ZÜRICH

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel - 19 genes)
Genetica AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Accreditation Diagnosis of predisposition to breast cancer and ovarian cancer (Panel)
CLCC Institut Gustave Roussy
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnostic of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 and PALB2 genes)
CLCC Institut Curie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FINLAND

Finland
HELSINKI

Accreditation Diagnosis of predisposition to breast and ovarian cancer
HUSLAB
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
BONN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
Universitätsklinikum Bonn (AöR)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
BELGIUM

LIEGE
LIEGE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (gene panel)
CHU de Liège - Domaine universitaire du Sart Tilman
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
AUSTRIA

OBERÖSTERREICH
LINZ

Accreditation Diagnosis of hereditary breast and ovarian cancer (BRCA1 and BRCA2 gene)
Ordensklinikum Linz GmbH Barmherzige Schwestern
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
BELGIUM

LIEGE
LIEGE

Accreditation Diagnosis of predisposition to hereditary cancers (broad panel of 26 genes)
CHU de Liège - Domaine universitaire du Sart Tilman
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
BELGIUM

ANTWERPEN
ANTWERPEN-EDEGEM

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (CHEK2 gene, hot spot mutation - c.1100delC)
Centrum Medische Genetica - UZA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
BELGIUM

HAINAUT
GOSSELIES

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome and Li-Fraumeni syndrome (CHEK2 gene, hot spot mutation- 1100delC)
Institut de Pathologie et de Génétique
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
BELGIUM

HAINAUT
GOSSELIES

Accreditation Diagnostic of hereditary cancers (gene panel)
Institut de Pathologie et de Génétique
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of inherited cancer-predisposing syndrome (Panel)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (HBOC Panel Mutation Targeted Research)
Laboratoire de biologie médicale GEN-BIO
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

NORMANDIE
ROUEN

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CHU de Rouen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

NORMANDIE
CAEN

Accreditation Diagnosis of susceptibility to Inherited Breast and Ovarian Cancer: Splicing Study (BRCA1, BRCA2, PALB2, RAD51C, RAD51D genes)
Centre François Baclesse
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of predispositions to hereditary Breast, Ovarian, Pancreatic and Prostate Cancer (Panel)
AP-HP.Centre - Université de Paris - Hôpital Cochin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

OCCITANIE
TOULOUSE

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (PARP Inhibitor Response Test)
IUCT Oncopole - CLCC Institut Claudius Regaud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Diagnosis of inherited gynecological cancer-predisposing syndrome (gene panel)
UZ Leuven - Campus Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation Diagnosis of hereditary cancer predisposition (gene panel)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of predisposition to tumors (breast, ovary, stomach, pancreas, colon) (Panel)
CHU de Strasbourg - Hôpital de Hautepierre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Comunidad Valenciana
PATERNA

Accreditation Diagnosis of hereditary breast and/or ovarian cancer syndrome (BRCA1 gene)
Sistemas Genómicos S.L.
Purpose(s) : Pre-implantation diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
BELGIUM

OOST-VLAANDEREN
GENT

Accreditation Diagnosis of rare tumors (gene panel)
AZ Sint Lucas Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CLCC Paul Strauss
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
ITALY

VENETO
CHIOGGIA

Accreditation Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
Laboratori Clodia Sas
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
CANADA

Ontario
OTTAWA

Accreditation Molecular Diagnosis of Hereditary Breast Cancer (sequence analysis, MLPA of BRCA1, BRCA2)
Children's Hospital of Eastern Ontario
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
CANADA

Ontario
KINGSTON

Accreditation Molecular Diagnosis of Hereditary Breast Cancer (BRCA1 and BRCA2 analysis)
Kingston General Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
CANADA

Ontario
LONDON

Accreditation Diagnosis of Hereditary Breast/Ovarian Cancer (NGS Panel 22 genes)
London Health Sciences Centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
CANADA

Ontario
LONDON

Accreditation Molecular Diagnosis of High Penetrance Hereditary Cancer Predisposition - Comprehensive NGS Panel (16 genes)
London Health Sciences Centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
CANADA

Ontario
LONDON

Accreditation Molecular Diagnosis of Hereditary Cancer (Comprehensive NGS Panel)
London Health Sciences Centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SWEDEN

Region Stockholm
SOLNA

Accreditation Diagnosis of hereditary cancer (Panel - GeneMate)
iCellate Medical AB
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
CREMONA

Diagnosis of hereditary breast and ovarian cancer [panel of genes]
ASST Cremona
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of breast and ovarian cancer (panel)
Hospital de la Santa Creu i Sant Pau
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis, Detection of microdeletions/microduplications
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
DÜSSELDORF

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
MVZ Düsseldorf-Centrum GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

VENETO
PADOVA

Molecular diagnosis of predisposition to hereditary familial breast ovary cancer (BRCA1 and BRCA2 genes determined by targeted mutation analysis, sequence analysis of the entire coding region and MLPA)
Istituto Oncologico Veneto IRCCS
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : MLPA based techniques

More information
ITALY

EMILIA ROMAGNA
PARMA

Diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
Azienda Ospedaliero-Universitaria di Parma
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
Centro Nacional de Investigaciones Oncológicas (CNIO)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Andalucía
SEVILLA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Hospital Universitario Virgen del Rocío
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of familial breast cancer (BRCA1, BRCA2 genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Universitario y Politécnico La Fe
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
ITALY

FRIULI VENEZIA GIULIA
AVIANO

Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes)
Centro di Riferimento Oncologico
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2 and PALB2 genes)
Azienda Ospedaliera Universitaria Policlinico di Tor Vergata
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Bayern
REGENSBURG

Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 11 genes)
Universität Regensburg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
BAD STEBEN

Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, PALB2, RAD51C, RAD51D genes)
Institut für angewandte Humangenetik und Onkogenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Clínic de Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
ITALY

TOSCANA
FIRENZE

Molecular diagnosis of breast cancer, familial (BRCA1, BRCA2 and PALB2 genes)
AOU Careggi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
DNA Data
Purpose(s) : Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
MILANO

Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
IRCCS Ospedale San Raffaele
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of familial breast cancer (BRCA1, BRCA2 genes)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
ITALY

TOSCANA
PISA

Diagnosis of hereditary breast and ovarian cancer [panel of genes]
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of proneness to familial breast cancer (BRCA1 and BRCA2 genes)
Laboratorio Genoma
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
Acibadem healthcare group
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of predisposition to breast and prostate cancer (BRCA1 and BRCA2 genes)
Genetiks - Genetic diagnosis and research center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
CENTOGENE GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

LOMBARDIA
MONZA

Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
Fondazione IRCCS San Gerardo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of the familial breast cancer (BRCA1 gene; SNP array)
DiNA Science
Purpose(s) : Pre-implantation diagnosis
Specialty(ies) : Molecular genetics, Other
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, PCR based techniques

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
INGEMM - Instituto de Genética Médica y Molecular (IdiPAZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Hamburg
HAMBURG

Diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, RAD51C genes)
Gemeinschaftspraxis für Humangenetik GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
ITALY

LOMBARDIA
VARESE

Molecular diagnosis with germinal mutation analysis of breast and ovary cancer susceptibility syndrome (BRCA1 and BRCA2 genes)
A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
POLAND

Warszawa
WARSAW

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
NZOZ GENOMED
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

EMILIA ROMAGNA
MELDOLA

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 and CHEK2 genes)
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 and RAD51C genes)
Health in Code. Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
POLAND

Poznan
POZNAN

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 gene: 5382insC, 4153delA, 300T/G and 3819del5 mutations)
Centrum Genetyki Medycznej GENESIS
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Bremen
BREMEN

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, RAD51C genes)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Niedersachsen
OSNABRÜCK

Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
POLAND

Wroclaw
WROCLAW

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene)
Przychodnia Fundacji Uniwersytetu Medycznego we Wroclawiu
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Sistemas Genómicos S.L.
Purpose(s) : Post-natal diagnosis, Pharmacogenetics, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Cataluña
BADALONA

Diagnosis of hereditary breast and ovarian cancer syndrome (PALB2 gene)
Hospital Germans Trias I Pujol
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes; large deletions by MLPA kit P002 (BRCA1), kit P045 (BRCA2))
Hospital Universitario Donostia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, RAD51C, RAD51D, TP53 genes)
MVZ Humangenetik Ulm GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
GERMANY

Baden-Württemberg
STUTTGART

Diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53, XRCC2 genes)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Sachsen
DRESDEN

Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, RAD51C, RAD51D, PALB2, PTEN)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
POLAND

Bydgoszcz
BYDGOSZCZ

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and CHEK2 genes)
Szpital Uniwersytecki im. dr. Antoniego Jurasza
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
ITALY

PIEMONTE
TORINO

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 genes)
A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

CAMPANIA
NAPOLI

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
CEINGE - Biotecnologie Avanzate Srl
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Hospital Universitari Vall d'Hebron
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Castilla - León
VALLADOLID

Diagnosis of hereditary to breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
IBGM - Instituto de Biología y Genética Molecular
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Hessen
WIESBADEN

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing)
IMD Humangenetik Wiesbaden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (gene panel)
Onkologikoa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Fundación Rioja Salud - Centro de Investigación Biomédica de La Rioja
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of predisposition to breast and ovarian cancer (NGS Screening Panel, 18 genes)
CENTOGENE GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
POLAND

Warszawa
WARSAW

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
MEDGEN
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : PCR based techniques, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
SANT JOAN D'ALACANT

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Centro Inmunológico de Alicante (CIALAB)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
FREIBURG

Diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, CHEK2, MRE11, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik am Universitätsklinikum Freiburg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital del Mar
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Cataluña
SABADELL

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Parc Taulí Hospital Universitari. Centre de Medicina Genòmica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
REUS

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Universitari de Sant Joan de Reus
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
ERLANGEN

Diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 19 genes)
Humangenetisches Institut am Universitätsklinikum Erlangen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Comunidad Valenciana
ELCHE

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Bioarray
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ITALY

MOLISE
POZZILLI

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
Istituto Neurologico Mediterraneo - IRCCS Neuromed
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
CANADA

Alberta
EDMONTON

Molecular Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome - NGS Core Panel (6 genes)
University of Alberta
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
CANADA

Alberta
EDMONTON

Molecular Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome - NGS Extended Panel (13 genes)
University of Alberta
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
FRANCE

OCCITANIE
MONTPELLIER

Diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (Panel)
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
ALICANTE

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 gene)
Instituto Bernabeu Biotech
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of genetic gynecological tumors and related disorders (panel, qCancer Gine)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of BRCA-associated cancer (panel, qCancer BRCAs)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of rare neoplastic diseases (panel, qCancer Risk)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary cancer (panel)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of inherited cancer risk (panel, qCancer Risk Extended)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Diagnosis of inherited cancer risk (panel)
ICO Hospitalet - Hospital Duran i Reynals
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Methylation analysis, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
ALICANTE

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Centro Médico V76
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of neurotransmitter defects and related diseases (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of Rett syndrome and epilepsy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of ventriculomegaly (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of breast and ovarian cancer (panel)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of hereditary cancer (panel)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of dwarfism (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Andalucía
GRANADA

Diagnosis of hereditary cancer (panel)
Hospital Universitario Virgen de las Nieves
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of intellectual disability (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of microcephaly (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of overgrowth syndrome (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of vasculopathy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of inherited cancer-predisposing syndrome (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of breast and ovarian cancer (panel)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
MONZA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Synlab ITALIA srl
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of rare diseases with defects in DNA-repair (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of epilepsy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of immunodeficiency (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Hessen
FRANKFURT AM MAIN

Diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, RAD51C, RAD51D, TP53 genes)
Senckenberg Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of autism (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
AUSTRIA

WIEN
WIEN

Diagnosis of hereditary breast and ovarian cancer (BRCA1 and BRCA2 gene)
Hanusch Krankenhaus
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Andalucía
MÁLAGA

Diagnosis of breast and ovarian cancer (panel)
Genologica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Fundación Instituto Valenciano de Oncología
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Galicia
A CORUÑA

Diagnosis of breast tumor (panel - 12 genes)
Health In Code. A Coruña
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Galicia
A CORUÑA

Diagnosis of ovarian cancer (panel - 12 genes)
Health In Code. A Coruña
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Galicia
A CORUÑA

Diagnosis of genetic cancer (panel - 128 genes)
Health In Code. A Coruña
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Baleares
PALMA DE MALLORCA

Diagnosis of hereditary breast and ovarian cancer (BRCA1, BRCA2, CHEK2 genes)
Hospital Universitari Son Espases
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of cancer (panel)
Fundación Instituto Valenciano de Oncología
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Galicia
SANTIAGO DE COMPOSTELA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Complejo Hospitalario Universitario de Santiago
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
ICO Hospitalet - Hospital Duran i Reynals
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Saarland
HOMBURG

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Bioscientia MVZ Labor Saar GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Asturias
OVIEDO

Diagnosis of inherited cancer (panel)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Asturias
OVIEDO

Diagnosis of rare tumor (panel)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
TERRASSA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Consorci Sanitari de Terrassa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Hospital Universitario Ramón y Cajal
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
STUTTGART

Diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51D, TP53 genes)
Praxis für Humangenetik und Prävention
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
NÜRNBERG

Diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Medizinisches Versorgungszentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
AUSTRIA

STEIERMARK
GRAZ

Diagnosis of hereditary breast and ovarian cancer (BRCA1 and BRCA2 gene)
Medizinische Universität Graz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Murcia
EL PALMAR

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Clínico Universitario Virgen de la Arrixaca
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Baleares
PALMA DE MALLORCA

Diagnosis of hereditary cancer (panel)
Hospital Universitari Son Espases
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Diagnosis of familial tumor syndromes (NGS screening panel: 35 genes)
MVZ Humangenetik Ulm GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Navarra
PAMPLONA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
CIMA - Centro de Investigación Médica Aplicada
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Navarra
PAMPLONA

Diagnosis of solid tumors (panel)
CIMA - Centro de Investigación Médica Aplicada
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of solid tumors (panel)
INCLIVA - Facultad de Medicina de la Universidad de Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Castilla - León
SALAMANCA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
BIOSALAB Molecular Biology Solutions
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Aragón
ZARAGOZA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Hospital Clínico Universitario "Lozano Blesa" de Zaragoza
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MAJADAHONDA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Instituto de Investigación Sanitaria Puerta de Hierro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of rare tumor (panel)
Seqplexing
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
MONTPELLIER

Diagnosis of predisposition to digestive tumor, breast and ovarian cancer syndrome (Panel)
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of familial cancer (panel)
Sistemas Genómicos S.L.
Purpose(s) : Post-natal diagnosis, Pharmacogenetics, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
MONTPELLIER

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
IURC - Institut Universitaire de Recherche Clinique
Purpose(s) : Pre-implantation diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

Andalucía
GRANADA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Hospital Universitario Virgen de las Nieves
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Aragón
ZARAGOZA

Diagnosis of hereditary breast and/or ovarian cancer syndrome
Hospital Universitario Miguel Servet
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Aragón
ZARAGOZA

Diagnosis of ovarian, breast, prostate and pancreatic cancers (BRCA1, BRCA2 genes)
Hospital Universitario Miguel Servet
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Castilla - León
SALAMANCA

Diagnosis of ovarian, breast, prostate and pancreatic cancers (BRCA1, BRCA2 genes)
BIOSALAB Molecular Biology Solutions
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SWITZERLAND

Suisse Romande
LAUSANNE

Diagnosis of predisposition to breast and ovarian cancer
Gene Predictis SA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
ITALY

EMILIA ROMAGNA
RIMINI

Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
Azienda Ospedaliera "Infermi"
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
FRANCE

GRAND-EST
REIMS

Diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes)
CLCC Institut Jean Godinot
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for familial breast cancer (BRCA1 17q21.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
Instituto Português de Oncologia do Porto Francisco Gentil, EPE - IPO Porto, EPE
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
PORTUGAL

SUL
LISBOA

Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
Faculdade de Medicina da Universidade de Lisboa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LIGURIA
GENOVA

Molecular diagnosis of familial breast cancer
IRCCS Policlinico San Martino - Istituto Nazionale per la Ricerca sul Cancro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ROMANIA

BUCURESTI
BUCURESTI

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
GeneticLab
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
ITALY

ABRUZZO
CHIETI

Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
Università degli Studi "G. D'Annunzio" - CESI-Met
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
NETHERLANDS

Noord-Holland
AMSTERDAM

Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1 and BRCA2 gene)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
PORTUGAL

SUL
LISBOA

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
NORWAY

Østlandet
OSLO

Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2)
Oslo University Hospital, Ullevaal
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CZECH REPUBLIC

South Moravia
BRNO

Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2)
Masaryk Memorial Cancer Institute
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CROATIA

CROATIA
ZAGREB

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Rudjer Boskovic Institute
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
ISRAEL

ISRAEL
JERUSALEM

Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
Hadassah Ein Kerem - Hebrew University Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
HAIFA

Molecular diagnosis of Breast cancer (BRCA1, BRCA2, Mutation analysis)
Carmel Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
REHOVOT

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
Kaplan Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
HAIFA

Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
RAMAT GAN

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis, PGD)
Sheba Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
PETAH TIKVA

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
Rabin Medical Center - Beilinson Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
BEER YAAKOV

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
Assaf Harofeh Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
JERUSALEM

Molecular diagnosis of Cancer: breast , ovary (BRCA1, BRCA2, Mutation analysis, PGD)
Shaare Zedek Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
HOLON

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
Wolfson Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
AFULA

Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
Emek Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Canarias
LA CUESTA

Diagnosis of hereditary breast and ovarian cancer syndrome
Hospital Universitario de Canarias
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of microdeletions/microduplications
Technique(s) : FISH

More information
ITALY

CAMPANIA
AVELLINO

Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
Azienda Ospedaliera San Giuseppe Moscati
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 gene: target mutation analysis - single mutation (187delAG (BRCA1), 5385insC (BRCA1), 6174delT(BRCA2), c.156_157insAlu (BRCA2), sequence analysis of the entire coding region, and deletion/dluplication analysis by MLPA)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
ITALY

LOMBARDIA
BRESCIA

Molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes)
Biodiversity
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
TEL AVIV

Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 full gene sequencing)
Pronto Diagnostics Ltd.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
LITHUANIA

DZUKIJA
VILNIUS

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Vilnius University Hospital Santariskiu Klinikos
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
ROMANIA

BUCURESTI
BUCURESTI

Postnatal molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes: deletion/duplication analysis by MLPA)
National institute of legal medicine
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
BONN

Diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
MVZ Institut für Klinische Genetik und Tumorgenetik Bonn GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
A.O. S. Andrea
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

SARDEGNA
CAGLIARI

Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
Ospedale "R. Binaghi"
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
USI - Unione Sanitaria Internazionale
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

PUGLIA
LECCE

Molecular diagnosis of predisposition to breast cancer (HER-2)
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

PUGLIA
LECCE

Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Galicia
A CORUÑA

Diagnosis of hereditary breast and ovarian cancer syndrome (panel)
Hospital Materno-Infantil Teresa Herrera
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Castilla - León
SALAMANCA

Diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, BRIP1, PALB2, RAD51C, BARD1, CHECK2 genes)
IBSAL - Instituto de Investigación Biomédica de Salamanca
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of Hereditary breast cancer syndrome (RAD51 gene: sequencing of the entire coding region)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (PTEN 10q23.31)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation for Breast and Ovarian Cancer (PTEN 10q23.31)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for familial breast cancer (BRCA2 13q13.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation of familial breast cancer (BRCA2 13q13.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation of familial breast cancer (BRCA1 13q21.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (STK11 19p13.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (STK11 19p13.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (CHEK2 22q12.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (ATM 11q22.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (ATM 11q22.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (PALB2 16p12.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (PALB2 16p12.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (BRIP1 17q23.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (BRIP1 17q23.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (BRAF 7q34)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (BRAF 7q34)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
CANADA

Alberta
CALGARY

Diagnosis of Predisposition to Hereditary Breast and Ovarian Cancer - NGS Core Panel (6 genes)
Alberta Children's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
CANADA

Alberta
CALGARY

Diagnosis of Predisposition to Hereditary Breast and Ovarian Cancer - NGS Extended Panel (13 genes)
Alberta Children's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
CANADA

Alberta
CALGARY

Pediatric Cancer NGS Panel (12 genes)
Alberta Children's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
AUSTRIA

WIEN
WIEN

Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, BRIP1, CHEK2, MRE11, NBN, PALB2, RAD51C, TP53, and RAD51D genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
PORTUGAL

NORTE
PORTO

Diagnosis of predisposition to breast and ovarian cancer (RAD51D gene)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
PORTUGAL

NORTE
PORTO

Diagnosis of predisposition to breast and ovarian cancer (TP53 gene)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
PORTUGAL

NORTE
PORTO

Diagnostic of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information